Gradient Investments’s CEMIG Preferred Shares CIG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-979
Closed -$1K 1195
2021
Q4
$1K Hold
979
﹤0.01% 1126
2021
Q3
$1K Hold
979
﹤0.01% 1058
2021
Q2
$1K Sell
979
-1
-0.1% -$1 ﹤0.01% 1050
2021
Q1
$1K Hold
980
﹤0.01% 1061
2020
Q4
$1K Hold
980
﹤0.01% 1023
2020
Q3
$1K Sell
980
-1
-0.1% -$1 ﹤0.01% 1028
2020
Q2
$1K Hold
981
﹤0.01% 953
2020
Q1
$1K Hold
981
﹤0.01% 973
2019
Q4
$2K Hold
981
﹤0.01% 925
2019
Q3
$2K Hold
981
﹤0.01% 912
2019
Q2
$2K Hold
981
﹤0.01% 864
2019
Q1
$2K Hold
981
﹤0.01% 737
2018
Q4
$2K Hold
981
﹤0.01% 811
2018
Q3
$1K Hold
981
﹤0.01% 888
2018
Q2
$1K Hold
981
﹤0.01% 880
2018
Q1
$1K Hold
981
﹤0.01% 883
2017
Q4
$1K Buy
+981
New +$1.11K ﹤0.01% 874
2016
Q4
Sell
-1,962
Closed -$3K 734
2016
Q3
$3K Buy
1,962
+981
+100% +$1.35K ﹤0.01% 577
2016
Q2
$1K Sell
981
-137
-12% -$125 ﹤0.01% 642
2016
Q1
$1K Buy
1,118
+137
+14% +$112 ﹤0.01% 652
2015
Q4
$1K Buy
+981
New +$906 ﹤0.01% 617
2013
Q3
Sell
-8
Closed 504
2013
Q2
$0 Buy
+8
New +$32 ﹤0.01% 474

Other funds holding CIG

Gradient Investments's CIG Position: Q1 2022 in Review

Gradient Investments sold out of CEMIG Preferred Shares (CIG) in Q1 2022, closing a stake of 979 shares — an estimated $1K sold.

Gradient Investments first reported a position in CIG in Q2 2013 and held it in 22 quarters. The position peaked at $3K in Q3 2016. 142 funds tracked by Wall St. Rank hold CIG as of Q1 2022.

  • Gradient Investments reported no remaining CEMIG Preferred Shares position as of Q1 2022 after selling out during the quarter.
  • Gradient Investments sold 979 CEMIG Preferred Shares shares in Q1 2022, an estimated $1K.
  • Gradient Investments first reported a position in CEMIG Preferred Shares in Q2 2013 and held it in 22 quarters.
  • Gradient Investments's CEMIG Preferred Shares position peaked at $3K in Q3 2016.
  • 142 funds tracked by Wall St. Rank held CEMIG Preferred Shares as of Q1 2022.

Based on Gradient Investments's 13F filing for Q1 2022, filed 26 May 2022.